By closely monitoring biomarkers such as serum sodium, PT/INR, albumin levels, and the presence of SBP and HE at presentation in patients with alcoholic cirrhosis, physicians might be able to predict patients who are more likely to be at risk of developing HRS and subsequently make prompt diagnoses and institute aggressive treatment. This evidence concerns the gene ALB and alcoholic liver cirrhosis.